Literature DB >> 31595425

miR-26 suppresses renal cell cancer via down-regulating coronin-3.

Xin Jun Wang1,2, Zhi Jian Yan1,2, Guang Cheng Luo3,4, Yi Yan Chen1, Pei Ming Bai1,2.   

Abstract

Coronin-3 (coronin-1C), a homotrimer F-actin-binding protein, has been reported to be important for metastasis in several types of cancers such as lung cancer, gastric cancer, and breast cancer. Here, we present an investigation of the expression and function of coronin-3 in renal cell cancer for the first time. We also confirmed that miR-26 directly targets coronin-3 and down-regulates its expression by western blot assay and dual-luciferase reporter system. The results of MTT and colony formation assay showed that miR-26 suppressed cell proliferation. Wound healing and transwell assay revealed that miR-26 inhibited migration and invasion of renal cancer cell. Moreover, overexpression of coronin-3 could reverse the miR-26-induced inhibition in cell growth and metastasis. Thus, our study suggests that coronin-3 should serve as a potential therapeutic target in renal cell cancer and provide a candidate for miRNA therapy.

Entities:  

Keywords:  Coronin-3; Invasion; Migration; Proliferation; Renal cell cancer; miR-26

Mesh:

Substances:

Year:  2019        PMID: 31595425     DOI: 10.1007/s11010-019-03636-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  17 in total

Review 1.  The coronin family of actin-associated proteins.

Authors:  E L de Hostos
Journal:  Trends Cell Biol       Date:  1999-09       Impact factor: 20.808

Review 2.  Mechanism of actin-based motility.

Authors:  D Pantaloni; C Le Clainche; M F Carlier
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

Review 3.  Coronins: the return of the crown.

Authors:  Andrea C Uetrecht; James E Bear
Journal:  Trends Cell Biol       Date:  2006-06-27       Impact factor: 20.808

Review 4.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 5.  Multimodal treatment of advanced renal cancer in 2017.

Authors:  Alessia Mennitto; Elena Verzoni; Paolo Grassi; Raffaele Ratta; Giovanni Fucà; Giuseppe Procopio
Journal:  Expert Rev Clin Pharmacol       Date:  2017-10-06       Impact factor: 5.045

6.  Down-regulation of miR-26 plays essential roles in TGFβ-induced EMT.

Authors:  Zhi-Gang Cai; Hai-Bo Wu; Xiao-Ping Xu; Wen Li
Journal:  Cell Biol Int       Date:  2018-07-04       Impact factor: 3.612

7.  Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma.

Authors:  Nijiro Nohata; Toyoyuki Hanazawa; Naoko Kikkawa; Muradil Mutallip; Lisa Fujimura; Hirofumi Yoshino; Kazumori Kawakami; Takeshi Chiyomaru; Hideki Enokida; Masayuki Nakagawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

8.  Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C.

Authors:  Hiroko Mataki; Hideki Enokida; Takeshi Chiyomaru; Keiko Mizuno; Ryosuke Matsushita; Yusuke Goto; Rika Nishikawa; Ikkou Higashimoto; Takuya Samukawa; Masayuki Nakagawa; Hiromasa Inoue; Naohiko Seki
Journal:  J Hum Genet       Date:  2014-12-18       Impact factor: 3.172

Review 9.  Cost of migration: invasion of malignant gliomas and implications for treatment.

Authors:  A Giese; R Bjerkvig; M E Berens; M Westphal
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

10.  Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.

Authors:  Dr Thal; C-P Xavier; A Rosentreter; S Linder; B Friedrichs; A Waha; T Pietsch; M Stumpf; Aa Noegel; Cs Clemen
Journal:  J Pathol       Date:  2008-03       Impact factor: 7.996

View more
  5 in total

1.  RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.

Authors:  Rui-Li Zhang; Ainiwaer Aimudula; Jiang-Hong Dai; Yong-Xing Bao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

2.  miR-128-3p serves as an oncogenic microRNA in osteosarcoma cells by downregulating ZC3H12D.

Authors:  Maoshu Zhu; Yulong Wu; Zhaowei Wang; Minghua Lin; Bin Su; Chunyang Li; Fulong Liang; Xinjiang Chen
Journal:  Oncol Lett       Date:  2020-12-31       Impact factor: 2.967

3.  Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer.

Authors:  Xiaobo He; Xiao Cheng; Jianfeng Ding; Maoming Xiong; Bo Chen; Guodong Cao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

4.  DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axis.

Authors:  Xin-Jun Wang; Lin Chen; Ran Xu; Si Li; Guang-Cheng Luo
Journal:  Clin Kidney J       Date:  2022-02-28

5.  Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells.

Authors:  Rania Harati; Aloïse Mabondzo; Abdelaziz Tlili; Ghalia Khoder; Mona Mahfood; Rifat Hamoudi
Journal:  Breast Cancer Res Treat       Date:  2021-05-26       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.